The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Current evidence and future research needs for FeNO measurement in respiratory diseases
Open accessAbstract
Although not yet widely implemented, fraction of exhaled nitric oxide (FeNO) has emerged in recent years as a potentially useful biomarker for the assessment of airway inflammation both in undiagnosed patients with non-specific respiratory symptoms and in those with established airway disease. Research to date essentially suggests that FeNO measurement facilitates the identification of patients exhibiting T-helper cell type 2 (Th2)-mediated airway inflammation, and effectively those in whom anti-inflammatory therapy, particularly inhaled corticosteroids (ICS), is beneficial. In some studies, FeNO-guided management of patients with established airway disease is associated with lower exacerbation rates, improvements in adherence to anti-inflammatory therapy, and the ability to predict risk of future exacerbations or decline in lung function. Despite these data, concerns regarding the applicability and utility of FeNO in clinical practice still remain. This article reviews the current evidence, both supportive and critical of FeNO measurement, in the diagnosis and management of asthma and other inflammatory airway diseases. It additionally provides suggestions regarding the practical application of FeNO measurement: how it could be integrated into routine clinical practice, how its utility could be assessed and its true value to both clinicians and patients could be established. Although some unanswered questions remain, current evidence suggests that FeNO is potentially a valuable tool for improving the personalised management of inflammatory airway diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-710st · Cited by 3,203
Dweik, R. A., Boggs, P. B., Erzurum, S. C., Irvin, C. G., Leigh, M. W., Lundberg, J. O., Olin, A.-C., Plummer, A. L., & Taylor, D. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.9120-11st · Cited by 2,539
Cited by
A European Respiratory Society technical standard: exhaled biomarkers in lung disease
Horváth, I., Barnes, P. J., Loukides, S., Sterk, P. J., Högman, M., Olin, A.-C., Amann, A., Antus, B., Baraldi, E., Bikov, A., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00965-2016 · Cited by 638
Current Understanding of Asthma Pathogenesis and Biomarkers
Habib, N., Pasha, M. A., & Tang, D. D. (2022) · Cells · doi:10.3390/cells11172764 · Cited by 299
Metadata
- Authors
- Bjermer, L., Alving, K., Diamant, Z., Magnussen, H., Pavord, I., Piacentini, G., Price, D., Roche, N., Sastre, J., Thomas, M., & Usmani, O.
- Venue
- Respiratory Medicine
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 108
- Issue
- 6
- Pages
- 830-841
- ISSN
- 0954-6111 (ISSN-L)
- OpenAlex
- W2030480367
- Cited by
- 185
- References
- 2
- FWCI
- 12.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current evidence and future research needs for FeNO measurement in respiratory diseases. https://app.cochat.ai/papers/10.1016/j.rmed.2014.02.005
- The paper
- Bjermer, L., Alving, K., Diamant, Z., Magnussen, H., Pavord, I., Piacentini, G., Price, D., Roche, N., Sastre, J., Thomas, M., & Usmani, O. (2014). Current evidence and future research needs for FeNO measurement in respiratory diseases. Respiratory Medicine. https://doi.org/10.1016/j.rmed.2014.02.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.